Home Cart Sign in  
Chemical Structure| 21187-98-4 Chemical Structure| 21187-98-4

Structure of Gliclazide
CAS No.: 21187-98-4

Chemical Structure| 21187-98-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Gliclazide is a blocker of pancreatic β-cell ATP-sensitive potassium channels with IC50 of 184 nM in murine. It belongs to the sulfonylurea class of insulin secretagoguesIt. Gliclazide is an antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

Synonyms: S1702; SE1702; S-852

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gliclazide

CAS No. :21187-98-4
Formula : C15H21N3O3S
M.W : 323.41
SMILES Code : O=S(C1=CC=C(C)C=C1)(NC(NN2CC3C(CCC3)C2)=O)=O
Synonyms :
S1702; SE1702; S-852
MDL No. :MFCD00409893
InChI Key :BOVGTQGAOIONJV-UHFFFAOYSA-N
Pubchem ID :3475

Safety of Gliclazide

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P264-P270-P301+P312+P330-P501

Isoform Comparison

Biological Activity

Target
  • Potassium Channel

    Potassium channel, IC50:184 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary β-cells 20 nM 12 h Gliclazide decreased C3 levels and inhibited islet β-cell dedifferentiation. iScience. 2024 Sep 28;27(10):111064.
MIN-6 cells 20 nM 12 h Gliclazide decreased C3 levels and inhibited islet β-cell dedifferentiation. iScience. 2024 Sep 28;27(10):111064.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Type 2 diabetes model Oral 6 mg/kg Once daily for one month Evaluate the effect of gliclazide on islet β-cell dedifferentiation in T2DM mice, results showed that gliclazide decreased C3 levels and inhibited β-cell dedifferentiation. iScience. 2024 Sep 28;27(10):111064.
Male Wistar rats Type 1 diabetes model Intra-arterial injection 20mg/kg Single dose, samples taken after 240 seconds To investigate the effect of deoxycholic acid on the permeation of gliclazide through the blood-brain barrier. Results showed increased penetration of gliclazide in diabetic animals, and DA pretreatment further enhanced penetration in both healthy and diabetic animals. J Diabetes Res. 2013;2013:598603
Male Golden Syrian hamsters 5-FU-induced oral mucositis model Oral gavage 1, 5, or 10 mg/kg Once daily for 10 days To evaluate the effect of gliclazide on 5-FU-induced oral mucositis. Results showed that gliclazide at 10 mg/kg significantly reduced oxidative stress and inflammation, and accelerated mucosal recovery. Front Physiol. 2019 Mar 26;10:327

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03705195 Type 2 Diabetes Mellitus COMPLETED 2019-06-26 Ninewells Hospital and Medical... More >> School, Dundee, DD1 9SY, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.09mL

0.62mL

0.31mL

15.46mL

3.09mL

1.55mL

30.92mL

6.18mL

3.09mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories